Abstract
Ecological risk assessment is generally carried out to assess the dose that may be harmful to particular species found in the freshwater. The ecological risk assessment is generally expressed through RQ or hazardous quotient, RQ < 0.1 suggests no risk, 0.1 ≤ RQ ≤ 1.0 suggests medium risk, and RQ > 1.0 suggests high risk to that particular species. Regarding this, the risk of nonsteroidal anti-inflammatory drugs (NSAIDs) has been particularly studied by several researchers in many countries because they are pharmaceuticals of high consumption by the population due to their analgesic, anti-inflammatory, and antipyretic properties, as well as their occurrence in different water bodies at different concentrations and the toxic effects reported in organisms that are exposed to them. Due to the results obtained, they have also been considered for future regulations, and in particular, diclofenac was added to the list of priority substances of the European Commission which should be monitored as water pollution agents in the European Union. In this chapter we will discuss some of these risk assessment studies as well as the legislation proposed by some countries for their regulation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Boxall ABA et al (2012) Pharmaceuticals and personal care products in the environment: what are the big questions? Environ Health Perspect 120(9):1221–1229. https://doi.org/10.1289/ehp.1104477
EMA (2006) EMEA Guidance for RA (June), pp 1–12. http://www.emea.eu.int
Ziylan A, Ince NH (2011) The occurrence and fate of anti-inflammatory and analgesic pharmaceuticals in sewage and fresh water: treatability by conventional and non-conventional processes. J Hazard Mater 187(1–3):24–36. https://doi.org/10.1016/j.jhazmat.2011.01.057
Mainero Rocca L et al (2015) Occurrence of non-steroidal anti-inflammatory drugs in surface waters of Central Italy by liquid chromatography–tandem mass spectrometry. Int J Environ Anal Chem 95(8):685–697. https://doi.org/10.1080/03067319.2015.1046059
Acuña V et al (2015) Occurrence and in-stream attenuation of wastewater-derived pharmaceuticals in Iberian rivers. Sci Total Environ 503–504:133–141. https://doi.org/10.1016/j.scitotenv.2014.05.067
Li Y et al (2019) Prioritization of pharmaceuticals in water environment in China based on environmental criteria and risk analysis of top-priority pharmaceuticals. J Environ Manage 253:109732. https://doi.org/10.1016/j.jenvman.2019.109732
Ashfaq M et al (2019) Occurrence, spatial variation and risk assessment of pharmaceuticals and personal care products in urban wastewater, canal surface water, and their sediments: a case study of Lahore, Pakistan. Sci Total Environ 688:653–663. https://doi.org/10.1016/j.scitotenv.2019.06.285
Kötke D et al (2019) Prioritised pharmaceuticals in German estuaries and coastal waters: Occurrence and environmental risk assessment. Environ Pollut 255(1):113161. https://doi.org/10.1016/j.envpol.2019.113161
Peña-Guzmán C et al (2019) Emerging pollutants in the urban water cycle in Latin America: a review of the current literature. J Environ Manage 237:408–423. https://doi.org/10.1016/j.jenvman.2019.02.100
Offiong N-A et al (2019) Risk evaluation of pharmaceutical residues in waste water from selected treatment plants in Gwangju, South Korea. J Chem Soc Nigeria 44(3):504–514
Gworek B et al (2019) Pharmaceuticals in aquatic environment. Fate and behaviour, ecotoxicology and risk assessment – a review. Acta Pol Pharm 76:397–407. https://doi.org/10.32383/appdr/103368
Česen M et al (2018) Seasonal and spatial variations in the occurrence, mass loadings and removal of compounds of emerging concern in the Slovene aqueous environment and environmental risk assessment. Environ Pollut 242:143–154. https://doi.org/10.1016/j.envpol.2018.06.052
Subari SN et al (2017) Occurrence, source apportionment and environmental risk assessment of pharmaceuticals in Klang river, Malaysia. Pertanika J Sci Technol 25:119–128
Kummerová M et al (2015) Possible ecological risk of two pharmaceuticals diclofenac and paracetamol demonstrated on a model plant Lemna minor. J Hazard Mater 302:351–361. https://doi.org/10.1016/j.jhazmat.2015.09.057
Lolić A et al (2015) Assessment of non-steroidal anti-inflammatory and analgesic pharmaceuticals in seawaters of North of Portugal: occurrence and environmental risk. Sci Total Environ 508:240–250. https://doi.org/10.1016/j.scitotenv.2014.11.097
la Farré M et al (2008) Fate and toxicity of emerging pollutants, their metabolites and transformation products in the aquatic environment. TrAC Trends Anal Chem 27(11):991–1007. https://doi.org/10.1016/j.trac.2008.09.010
Gonzalez-Rey M, Bebianno MJ (2014) Effects of non-steroidal anti-inflammatory drug (NSAID) diclofenac exposure in mussel Mytilus galloprovincialis. Aquat Toxicol 148:818–831. https://doi.org/10.1016/j.aquatox.2014.01.011
Pounds N et al (2008) Acute and chronic effects of ibuprofen in the mollusc Planorbis carinatus (Gastropoda: Planorbidae). Ecotoxicol Environ Saf 70(1):47–52. https://doi.org/10.1016/j.ecoenv.2007.07.003
Hernando MD et al (2006) Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 69(2 SPEC. ISS):334–342. https://doi.org/10.1016/j.talanta.2005.09.037
Yamamoto H et al (2007) Initial ecological risk assessment of eight selected human pharmaceuticals in Japan. Environ Sci 14(4):177–193
Kim Y et al (2007) Aquatic toxicity of acetaminophen, carbamazepine, cimetidine, diltiazem and six major sulfonamides, and their potential ecological risks in Korea. Environ Int 33(3):370–375. https://doi.org/10.1016/j.envint.2006.11.017
Santos JL, Aparicio I, Alonso E (2007) Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). Environ Int 33(4):596–601. https://doi.org/10.1016/j.envint.2006.09.014
Martín J et al (2012) Occurrence of pharmaceutical compounds in wastewater and sludge from wastewater treatment plants: removal and ecotoxicological impact of wastewater discharges and sludge disposal. J Hazard Mater 239–240:40–47. https://doi.org/10.1016/j.jhazmat.2012.04.068
Bouissou-Schurtz C et al (2014) Ecological risk assessment of the presence of pharmaceutical residues in a French national water survey. Regul Toxicol Pharmacol 69(3):296–303. https://doi.org/10.1016/j.yrtph.2014.04.006
Gamarra JS et al (2015) Environmental Risk Assessment (ERA) of diclofenac and ibuprofen: a public health perspective. Chemosphere 120:462–469. https://doi.org/10.1016/j.chemosphere.2014.08.020
Mendoza A et al (2015) Pharmaceuticals and iodinated contrast media in a hospital wastewater: a case study to analyse their presence and characterise their environmental risk and hazard. Environ Res 140:225–241. https://doi.org/10.1016/j.envres.2015.04.003
Papageorgiou M, Kosma C, Lambropoulou D (2016) Seasonal occurrence, removal, mass loading and environmental risk assessment of 55 pharmaceuticals and personal care products in a municipal wastewater treatment plant in Central Greece. Sci Total Environ 543:547–569. https://doi.org/10.1016/j.scitotenv.2015.11.047
Rivera-Jaimes JA et al (2018) Study of pharmaceuticals in surface and wastewater from Cuernavaca, Morelos, Mexico: occurrence and environmental risk assessment. Sci Total Environ 613–614:1263–1274. https://doi.org/10.1016/j.scitotenv.2017.09.134
Biel-Maeso M et al (2018) Occurrence, distribution and environmental risk of pharmaceutically active compounds (PhACs) in coastal and ocean waters from the Gulf of Cadiz (SW Spain). Sci Total Environ 612:649–659. https://doi.org/10.1016/j.scitotenv.2017.08.279
EC (2003) European Commission document on risk assessment. Technical guidance document on risk assessment part II, p 337. doi:https://doi.org/10.1002/mp.12308
Na TW et al (2019) Distribution and ecological risk of pharmaceuticals in surface water of the Yeongsan river, Republic of Korea. Ecotoxicol Environ Saf 181(May):180–186. https://doi.org/10.1016/j.ecoenv.2019.06.004
Nantaba F et al (2020) Occurrence, distribution, and ecotoxicological risk assessment of selected pharmaceutical compounds in water from Lake Victoria, Uganda. Chemosphere 239:124642. https://doi.org/10.1016/j.chemosphere.2019.124642
Miarov O et al (2020) A critical evaluation of comparative regulatory strategies for monitoring pharmaceuticals in recycled wastewater. J Environ Manage 254:109794. https://doi.org/10.1016/j.jenvman.2019.109794
Jelic A et al (2012) Occurrence and elimination of pharmaceuticals during conventional wastewater treatment. In: Emerging and priority pollutants in rivers. Springer, Berlin, pp 1–23
SWRCB (2015) State Water Resources Control Board, 2013. Regulations Related to Recycled Water, California, USA. https://www.waterboards.ca.gov/drinking_water/certlic/drinkingwater/documents/law_book/RWregulations_20150716.pdf
OCWD (2017) Orange County Water District, California, USA. Groundwater Replenishment System. Annual report 2016. https://www.ocwd.com/media/5630/2016-gwrs-annual-report.pdf
OCWD (2017) Orange County Water District, California, USA. Groundwater Replenishment System. https://www.ocwd.com/gwrs/about-gwrs/
EAWAG (2016) Swiss Federal Institute of Aquatic Science and Technology. Expert insight: Switzerland’s early lessons on micropollutants in wastewater. https://www.aquastrategy.com/article/expert-insight-switzerlands-early-lessons-micropollutants-wastewater
SR 814.201.231 (2016) Swiss regulation of DETEC to verify the elimination effect of measures of trace organic matter in sewage treatment plants. https://www.admin.ch/opc/de/official-compilation/2016/4049.pdf (in German)
DAWR (2009) Department of Agriculture and Water Resources, Australian Government. Australian guidelines for water recycling 2006–2009. http://agriculture.gov.au/water/quality/nwqms#guidelines
GWADH (2010) Government of Western Australia, Department of Health. Groundwater Replenishment Publications Premiers Collaborative Research Program: “Characterizing treated wastewater for drinking purposes following reverse osmosis treatment”. http://ww2.health.wa.gov.au/Articles/F_I/Groundwater-replenishment-publications
Water Corporation (2017) Australia: groundwater replenishment scheme. https://www.watercorporation.com.au/water-supply/ongoing-works/groundwater-replenishment-scheme
Water Corporation (2017) Australia: our wastewater treatment plants. https://www.watercorporation.com.au/water-supply/ongoing-works/groundwater-replenishment-scheme
PUB (2019) Singapore’s national water agency. NEWater. https://www.pub.gov.sg/watersupply/fournationaltaps/newater
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Cardoso-Vera, J.D., Islas-Flores, H., SanJuan-Reyes, N., Gómez-Oliván, L.M. (2020). Risk Evaluation and Legal Framework of the Nonsteroidal Anti-inflammatory Drugs Around the World. In: Gómez-Oliván, L.M. (eds) Non-Steroidal Anti-Inflammatory Drugs in Water. The Handbook of Environmental Chemistry, vol 96. Springer, Cham. https://doi.org/10.1007/698_2020_555
Download citation
DOI: https://doi.org/10.1007/698_2020_555
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-56293-9
Online ISBN: 978-3-030-56294-6
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)